Researchers Link Hormone Treatments to Heightened Risk of Brain Tumors
Scientists at the National Agency for Medicines and Health Products Safety in France recently linked the use of hormone treatments by women to a heightened risk of women developing benign brain tumors. During their research, they determined that prolonged use of some progestogen drugs was associated with a higher risk of meningioma. This sentiment isn’t shared by all, however, with one leading expert noting that while the risk of meningioma was higher in women who took the drugs for more than one year, the finding need not worry present or past users as heightened risk remained small. Meningiomas are common…
